Recipient of federal assistance · NEW YORK, NY

CORIDEA, LLC

CORIDEA, LLC received $5.1M in federal grants and other assistance in FY2026, on 8 actions, +38% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $15.7M. Its largest awarding agency was National Institutes of Health ($5.1M).

Assistance · FY2026
$5.1M
New awards
2
Actions
8
Since FY2021
$15.7M
UEI
L5D8PHYBNJH7
Location
NEW YORK, NY
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1.9MFY2021
  2. 1.8MFY2022
  3. 1.8MFY2023
  4. 1.3MFY2024
  5. 3.7MFY2025
  6. 5.1MFY2026

By type

  1. Grants$5.1M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.279 · Drug Use and Addiction Research Programs$3.4M68%
  2. 93.837 · Cardiovascular Diseases Research$1.6M32%
  3. 93.395 · Cancer Treatment Research-$5860.0%

Awarding agencies

  1. National Institutes of Health$5.1M100%
    Department of Health and Human Services

Largest awards

  1. TRANSCUTANEOUS PHRENIC NERVE STIMULATION FOR TREATING OPIOID OVERDOSE - PROJECT SUMMARY. THIS UG3/UH3 PROJECT IS FOCUSED ON THE DEVELOPMENT…$6.1M
    93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Cooperative agreement· Sep 15, 2025 – Sep 8, 2026· UH3DA058439
  2. ENT-BASED APPROACH TO CERVICAL PHRENIC NERVE STIMULATION FOR THE TREATMENT OF CENTRAL SLEEP APNEA - PROJECT SUMMARY CENTRAL SLEEP APNEA…$2M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Sep 11, 2025 – Aug 31, 2026· R44HL178050
  3. MINIMALLY INVASIVE HIGH INTENSITY THERAPEUTIC ULTRASOUND FOR THE TREATMENT OF OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - PROJECT SUMMARY…$2M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Apr 30, 2023 – Jun 2, 2026· R44HL167428
  4. NOVEL MINIMALLY INVASIVE ENDOBRONCHIAL APPROACH FOR LUNG CANCER ABLATION - PROJECT SUMMARY: LUNG CANCER IS ONE OF THE MOST AGGRESSIVE AND…$1.6M
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Sep 24, 2021 – Feb 18, 2026· R44CA239829
  5. TRANSCUTANEOUS PHRENIC NERVE STIMULATION FOR TREATING OPIOID OVERDOSE - IN THE U.S., AN EXPONENTIAL INCREASE IN OPIOID-RELATED OVERDOSE…$927.3K
    93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Cooperative agreement· Sep 1, 2023 – Feb 18, 2026· UG3DA058439
  6. COOLED RF BRONCHOSCOPIC LUNG VOLUME REDUCTION - PROJECT SUMMARY IN THE UNITED STATES, CHRONIC OBSTRUCTIVE PULMONARY DISORDER (COPD), RANKS…$305.4K
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Sep 1, 2026 – Sep 1, 2026· R43HL186091

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026 · FY2021–FY2026.